Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 5/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL334225 | 0.96 | MGLL (0.54) | MGLLALDH1A1MAPK1L3MBTL1EPHX2 | |
| SCHEMBL27312109 | 0.94 | MGLL (0.55) | MGLLALDH1A1MAPK1L3MBTL1EPHX2 | |
| SCHEMBL335071 | 0.91 | ALDH1A1 (0.53) | MGLLALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL27312116 | 0.85 | MGLL (0.49) | MGLLALDH1A1MAPK1L3MBTL1EPHX2 | |
| SCHEMBL334732 | 0.81 | ALDH1A1 (0.56) | MGLLALDH1A1MAPK1L3MBTL1MEN1 | |
| SCHEMBL21768202 | 0.81 | MAPT (0.44) | MGLLALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL18673 | 0.81 | ALDH1A1 (0.68) | ALDH1A1MAPK1L3MBTL1EPHX2MEN1 | |
| SCHEMBL3963428 | 0.81 | ALDH1A1 (0.68) | ALDH1A1MAPK1L3MBTL1EPHX2MEN1 | |
| SCHEMBL334237 | 0.79 | ALDH1A1 (0.61) | ALDH1A1MAPK1L3MBTL1EPHX2MEN1 | |
| SCHEMBL20624816 | 0.79 | ALDH1A1 (0.66) | MGLLALDH1A1MAPK1L3MBTL1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12030987-B2 | Aliphatic polycarbonate | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2024-07-09 | — | — | US | disclosed |
| US-12030987-B2 | Aliphatic polycarbonate | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2024-07-09 | — | — | US | disclosed |
| US-20220098364-A1 | ALIPHATIC POLYCARBONATE | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2022-03-31 | — | — | US | disclosed |
| US-8097708-B2 | 10a-Azalide compound | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2012-01-17 | — | — | US | disclosed |
| US-20090281292-A1 | 10a-Azalide Compound | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2009-11-12 | — | — | US | disclosed |
| EP-1985620-A1 | 10a-AZALIDE COMPOUND | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2008-10-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090281292-A1 | 10a-Azalide Compound | IL17A, AZI2, HDAC9 | MGLL 1506/4885ALDH1A1 1939/4885MAPK1 2104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.